{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:24:26Z","timestamp":1792265066713,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11060-024-04895-w","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T19:28:36Z","timestamp":1733513316000},"page":"177-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patterns of failure after stereotactic radiosurgery for brain metastases from small cell lung cancer: outcomes in the immunotherapy era"],"prefix":"10.1007","volume":"172","author":[{"given":"Alexander S.","family":"Marwaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Shepard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Karlovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney E.","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,7]]},"reference":[{"key":"4895_CR1","first-page":"35","volume":"2","author":"R Komaki","year":"1985","unstructured":"Komaki R (1985) Prophylactic cranial irradiation for small cell carcinoma of the lung. Cancer Treat Symp 2:35\u201339","journal-title":"Cancer Treat Symp"},{"key":"4895_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/jnci\/87.3.183","volume":"87","author":"R Arriagada","year":"1995","unstructured":"Arriagada R, Le Chevalier T, Borie F et al (1995) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87:183\u2013190","journal-title":"J Natl Cancer Inst"},{"key":"4895_CR3","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1002\/1097-0142(19821201)50:11<2433::AID-CNCR2820501131>3.0.CO;2-E","volume":"50","author":"FR Hirsch","year":"1982","unstructured":"Hirsch FR, Paulson OB, Hansen HH et al (1982) Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings. Cancer 50:2433\u20132437","journal-title":"Cancer"},{"key":"4895_CR4","unstructured":"National Comprehensive Cancer Network (2024) Bone cancer (version 2.2025). http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site"},{"issue":"10","key":"4895_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1200\/JCO.19.02767","volume":"38","author":"PD Brown","year":"2020","unstructured":"Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Anderson BM, for NRG Oncology (2020) Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol Off J Am Soc Clin Oncol 38(10):1019\u20131029. https:\/\/doi.org\/10.1200\/JCO.19.02767","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"4895_CR6","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","volume":"6","author":"CG Rusthoven","year":"2020","unstructured":"Rusthoven CG, Yamamoto M, Bernhardt D, Smith DE, Gao D, Serizawa T, Yomo S, Aiyama H, Higuchi Y, Shuto T, Akabane A, Sato Y, Niranjan A, Faramand AM, Lunsford LD, McInerney J, Tuanquin LC, Zacharia BE, Chiang V, Singh C, Robin TP (2020) Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study. JAMA Oncol 6(7):1028\u20131037. https:\/\/doi.org\/10.1001\/jamaoncol.2020.1271","journal-title":"JAMA Oncol"},{"issue":"8","key":"4895_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/jnci\/djad073","volume":"115","author":"CG Rusthoven","year":"2023","unstructured":"Rusthoven CG, Staley AW, Gao D, Yomo S, Bernhardt D, Wandrey N, El Shafie R, Kraemer A, Padilla O, Chiang V, Faramand AM, Palmer JD, Zacharia BE, Wegner RE, Hattangadi-Gluth JA, Levy A, Bernstein K, Mathieu D, Cagney DN, Chan MD, Yamamoto M (2023) Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE). J Natl Cancer Inst 115(8):926\u2013936. https:\/\/doi.org\/10.1093\/jnci\/djad073","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"4895_CR8","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","volume":"379","author":"L Horn","year":"2018","unstructured":"Horn L, Mansfield AS, Szcz\u0119sna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, IMpower133 Study Group (2018) First-line Atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med 379(23):2220\u20132229. https:\/\/doi.org\/10.1056\/NEJMoa1809064","journal-title":"N Engl J Med"},{"issue":"21","key":"4895_CR9","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","volume":"389","author":"D Planchard","year":"2023","unstructured":"Planchard D, J\u00e4nne PA, Cheng Y, Yang JC, Yanagitani N, Kim SW, Sugawara S, Yu Y, Fan Y, Geater SL, Laktionov K, Lee CK, Valdiviezo N, Ahmed S, Maurel JM, Andrasina I, Goldman J, Ghiorghiu D, Rukazenkov Y, Todd A, FLAURA2 Investigators (2023) Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC. N Engl J Med 389(21):1935\u20131948. https:\/\/doi.org\/10.1056\/NEJMoa2306434","journal-title":"N Engl J Med"},{"issue":"7","key":"4895_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1200\/JCO.23.02219","volume":"42","author":"PA J\u00e4nne","year":"2024","unstructured":"J\u00e4nne PA, Planchard D, Kobayashi K, Cheng Y, Lee CK, Valdiviezo N, Laktionov K, Yang TY, Yu Y, Kato T, Jiang L, Chewaskulyong B, Lucien Geater S, Maurel JM, Rojas C, Takahashi T, Havel L, Shepherd FA, Tanaka K, Ghiorghiu D, Yang JC (2024) CNS efficacy of osimertinib with or without chemotherapy in epidermal growth factor receptor-mutated advanced non-small-cell lung cancer. J Clin Oncol Off J Am Soc Clin Oncol 42(7):808\u2013820. https:\/\/doi.org\/10.1200\/JCO.23.02219","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"19","key":"4895_CR11","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.3390\/cancers16193388","volume":"16","author":"T Ranjan","year":"2024","unstructured":"Ranjan T, Podder V, Margolin K, Velcheti V, Maharaj A, Ahluwalia MS (2024) Immune checkpoint inhibitors in the management of brain metastases from non-small cell lung cancer: a comprehensive review of current trials, guidelines and future directions. Cancers 16(19):3388. https:\/\/doi.org\/10.3390\/cancers16193388","journal-title":"Cancers"},{"issue":"6","key":"4895_CR12","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Response Assessment in Neuro-Oncology (RANO) group (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270\u2013e278. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","journal-title":"Lancet Oncol"},{"issue":"5","key":"4895_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5152\/ThoracResPract.2023.23025","volume":"24","author":"FY Da\u015fg\u0131n","year":"2023","unstructured":"Da\u015fg\u0131n FY, Karg\u0131o\u011flu T, Arslan A, Aksakal AK, Dadak B, Ayrak FB, G\u00f6k\u00e7e E, Aral \u0130P, Alt\u0131n\u0131\u015f\u0131k \u0130nan G, Tezcan Y (2023) Stereotactic radiosurgery results in non-small-cell lung cancer patients with brain metastases in the era of modern systemic treatment agents. Thorac Res Pract 24(5):270\u2013275. https:\/\/doi.org\/10.5152\/ThoracResPract.2023.23025","journal-title":"Thorac Res Pract"},{"issue":"2","key":"4895_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cllc.2020.10.014","volume":"22","author":"TL Enright","year":"2021","unstructured":"Enright TL, Witt JS, Burr AR, Yadav P, Leal T, Baschnagel AM (2021) Combined immunotherapy and stereotactic radiotherapy improves neurologic outcomes in patients with non-small-cell lung cancer brain metastases. Clin Lung Cancer 22(2):110\u2013119. https:\/\/doi.org\/10.1016\/j.cllc.2020.10.014","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"4895_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.5603\/RPOR.a2022.0050","volume":"27","author":"M Martin","year":"2022","unstructured":"Martin M, Hernanz R, Vallejo C, Guerrero L, Mielgo X, Lopez A, Trujillo-Reyes JC, Cou\u00f1ago F (2022) Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies. Rep Pract Oncol Radiother J Greatpoland Cancer Center Poznan Polish Soc Radiat Oncol 27(3):527\u2013544. https:\/\/doi.org\/10.5603\/RPOR.a2022.0050","journal-title":"Rep Pract Oncol Radiother J Greatpoland Cancer Center Poznan Polish Soc Radiat Oncol"},{"key":"4895_CR16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS9082","author":"HJ Ross","year":"2020","unstructured":"Ross HJ et al (2020) NRG oncology\/alliance LU005: a phase II\/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer. JCO. https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.TPS9082","journal-title":"JCO"},{"key":"4895_CR17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA5","author":"DR Spigel","year":"2024","unstructured":"Spigel DR et al (2024) ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC). JCO. https:\/\/doi.org\/10.1200\/JCO.2024.42.17_suppl.LBA5","journal-title":"JCO"},{"issue":"1","key":"4895_CR18","doi-asserted-by":"publisher","first-page":"vdad018","DOI":"10.1093\/noajnl\/vdad018","volume":"5","author":"P Wong","year":"2023","unstructured":"Wong P, Masucci L, Florescu M, Plourde ME, Panet-Raymond V, Pavic M, Owen S, Masson-Cot\u00e9 L, M\u00e9nard C, Routy B, Tehfe M, Nelson K, Guilbert F, Boucher O, Keshavarzi S, Blais N, Roberge D (2023) Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases. Neuro-oncol Adv 5(1):vdad018. https:\/\/doi.org\/10.1093\/noajnl\/vdad018","journal-title":"Neuro-oncol Adv"},{"key":"4895_CR19","unstructured":"Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain (RAD 1704) (2022) ClinicalTrials.gov. National Library of Medicine. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03488472"},{"key":"4895_CR20","unstructured":"PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer (PICARES) (2019) ClinicalTrials.gov. National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT03971214"},{"issue":"2","key":"4895_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jtho.2019.10.001","volume":"15","author":"JW Welsh","year":"2020","unstructured":"Welsh JW, Heymach JV, Chen D, Verma V, Cushman TR, Hess KR, Shroff G, Tang C, Skoulidis F, Jeter M, Menon H, Nguyen QN, Chang JY, Altan M, Papadimitrakopoulou VA, Simon GR, Raju U, Byers L, Glisson B (2020) Phase I trial of pembrolizumab and radiation therapy after induction chemotherapy for extensive-stage small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 15(2):266\u2013273. https:\/\/doi.org\/10.1016\/j.jtho.2019.10.001","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"4","key":"4895_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, M\u00e9nard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316(4):401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"key":"4895_CR23","unstructured":"Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability (2021) ClinicalTrials.gov. National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04804644"},{"key":"4895_CR24","unstructured":"S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients with Small Cell Lung Cancer (2020) ClinicalTrials.gov. National Library of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04155034"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04895-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T17:11:43Z","timestamp":1739812303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04895-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["4895"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04895-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5350119\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,7]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}